about
Genetic considerations in the prenatal diagnosis of overgrowth syndromesUtility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy.Delivery of the growth restricted preterm fetus.Circulating cell-free DNA levels increase variably following chorionic villus sampling.Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.Promises, pitfalls and practicalities of prenatal whole exome sequencing.Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study.A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMIReproductive issues for adults with autosomal dominant polycystic kidney disease.A single center's experience with noninvasive prenatal testing.Advances in genetic prenatal diagnosis and screening.Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing.Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.Look before you leap: genomic screening in obstetrics and gynecology.Prenatal Diagnosis: Screening and Diagnostic Tools.Cell free DNA testing-interpretation of results using an online calculator.Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease.Trisomy 13-confined placental mosaicism: is there an increased risk of gestational hypertensive disorders?Investigating the Role of Fetal Gene Expression in Preterm Birth.Ethical and Counseling Challenges in Prenatal Exome SequencingTriplet ultrasound growth parametersCornual placenta accreta managed by postpartum total laparoscopic hysterectomyMore chorionic villi obtained at a single center compared to previously published reportsNoninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with cautionFetal phenotypes emerge as genetic technologies become robustTelehealth to provide prenatal genetics services: Feasibility and importance revealed during global pandemicAn approach to integrating exome sequencing for fetal structural anomalies into clinical practiceIn reply
P50
Q28252301-92CCA030-8D9E-4E80-A7A9-EBD48000F44DQ33699830-953C2950-45AD-4938-BD5E-B6A44BE82F21Q33699836-0AE65058-203F-4ADE-AA6A-FECA9FED6466Q34250874-3F6E80A5-6806-479B-90C8-9AEF372A5C2CQ34484712-67394F76-C357-4C12-82AD-11E722244AC2Q34558273-8AC2C467-6D9F-4C38-A4F1-85EC1CB5115EQ35099624-D34C112E-C61B-43BF-A826-B8289A5B7376Q36205202-6E43CC93-6169-443F-AD05-9D2086ADFCE4Q37063775-845D1B13-AC59-4C7E-B197-C26A2B5D62E8Q38199941-9C592CD2-C4D3-42B3-81BB-88F2F617BCEEQ38248328-48E278AC-AFC3-4757-9CE6-46238B278CD7Q38449983-BE0000E7-260A-4913-A282-F21182B99245Q38928166-A7D8203D-8FBB-49BD-B478-646B37FBB3CBQ39003730-073891E3-FB89-4594-89F2-C6308F614274Q39302986-089A9858-A92E-4E46-979D-2F3A71DBABC5Q40958359-AE894F49-6569-4DA5-8866-8CD1A1271E50Q44602113-F18E5AD1-B05B-49CA-B4BE-D7437E3A0A8AQ48186123-87477D26-3856-4C87-825D-9D618EBE7943Q51152022-7F12053D-B754-4359-8CF8-1D41130A889DQ56517284-13B44F24-FE95-4614-9F55-7433458EBF76Q82687156-0B9B91D0-7373-4495-A5E1-B473E70ECBC6Q86851451-532A7467-A7B2-46C5-8DFF-B3E3560B6223Q87404905-4C26B15B-F635-4519-970C-EFC818C99AF2Q87790056-EDD2B292-290F-4EA3-86CE-59D43005E03EQ92079877-06C9A9C2-D7BF-4586-821A-C01B036781FBQ92107557-132D01CD-802D-4E04-870B-D1D8A18FE4B8Q92890314-54CB1120-B6E5-4228-8536-BA86B6F9CFF5Q95449728-44CD68BE-397F-4A2B-B5B0-7EAA0B4DCEAD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Neeta L. Vora
@ast
Neeta L. Vora
@en
Neeta L. Vora
@es
Neeta L. Vora
@nl
Neeta L. Vora
@sl
type
label
Neeta L. Vora
@ast
Neeta L. Vora
@en
Neeta L. Vora
@es
Neeta L. Vora
@nl
Neeta L. Vora
@sl
prefLabel
Neeta L. Vora
@ast
Neeta L. Vora
@en
Neeta L. Vora
@es
Neeta L. Vora
@nl
Neeta L. Vora
@sl
P106
P1153
23398987600
P31
P496
0000-0002-2504-9455